Birmingham, West Midlands -- (SBWIRE) -- 01/22/2014 -- Value Penny Stocks issues special report on Dendreon Corporation (NASDAQ:DNDN), Iridium Communications Inc. (NASDAQ:IRDM), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Pan American Silver Corp. (USA) (NASDAQ:PAAS).
Dendreon Corporation (NASDAQ:DNDN) ended its recent business day with the gain of 1.26% and closed at the price of $3.22 after opening at $3.25. The stock traded during its last trading session with the total volume of 2,391,584 shares, as compared to its average volume of 4.53 million shares. Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. Its product portfolio includes active cellular immunotherapy and small molecule product candidates to treat a range of cancers.
Will DNDN Continue To Move Higher? Find Out Here
Iridium Communications Inc. (NASDAQ:IRDM) remained among the day advancers and traded with volume of 2,358,277 shares in the last session, as compared to average volume of 970,234.00 shares. In comparison with 52 week range of $5.37 - $9.22, it faced lowest price of $6.36 during the last trading session whereas its day highest price was $6.90. The company’s total market capitalization is $527.21 billion, along with 76.63 million shares outstanding. Iridium Communications Inc. provides mobile voice and data communications services through satellites to businesses, the U.S. and foreign governments, non-governmental organizations, and consumers worldwide.
Why Should Investors Buy IRDM After The Recent Gain? Just Go Here and Find Out
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) showed 2,350,382 shares in volume during the last trading session, while the average trading volume remained 2.27 million shares. The stock kicked off its trading session at $4.18 and closed at $4.20 after mounting 1.94%. Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection.
For How Long ACHN will Fight for Profitability? Read This Trend Analysis report
Pan American Silver Corp. (USA) (NASDAQ:PAAS) stock traded during its last trading session with the total traded volume of 2,334,104 shares versus its average volume of 1.94 million shares. The company opened its trade at the price of $12.85 and its closing price was $13.11 after gaining 1.71% for the day. Pan American Silver Corp. engages in the exploration, development, and operation of silver producing properties and assets. It produces and sells silver, gold, copper, lead, and zinc.
Why Should Investors Buy PAAS After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)